期刊文献+

IL-15基因修饰的NK细胞对原代卵巢癌细胞的杀伤作用 被引量:1

Cytotoxic activity of IL-15 gene modified-NK cells against primary ovarian cancer cells
下载PDF
导出
摘要 目的:探讨γ射线照射后的IL-15基因修饰的NK细胞(简称NK-ustc细胞)对原代卵巢癌细胞的体内外杀伤活性。方法:分离卵巢癌患者腹水原代卵巢癌细胞。不同剂量γ射线(0、1、2、4、8、16 Gy)照射NK-ustc细胞,3H-TdR掺入法检测照射后NK-ustc细胞的增殖情况,51Cr释放法检测NK-ustc细胞对K562和原代卵巢癌细胞的杀伤活性。建立人裸鼠荷卵巢癌模型,随机分为NK-ustc治疗组(模型鼠腹腔注射辐照后的NK-ustc细胞)和培养基对照组,同时设空白对照组(正常裸鼠腹腔注射辐照后的NK-ustc细胞),观察各组裸鼠体重、腹围及生存期。结果:1、2、4、8、16 Gy辐照后NK-ustc细胞的增殖率分别为(62.1±9.8)%、(41.3±8.7)%、(14.6±4.1)%、(0.1±0.03)%和(0.2±0.04)%。当效靶比为10∶1时,0、8 Gy辐照后NK-ustc细胞对K562的杀伤率分别为(45.4±8.9)%和(43.1±6.4)%,对原代卵巢癌细胞的杀伤率分别为(54.6±6.4)%和(48.3±5.8)%,说明辐照不影响NK-ustc细胞的杀伤活性(P>0.05)。辐照后NK-ustc细胞治疗组荷瘤小鼠的中位生存期为75 d,对照组为39 d(P<0.05),空白对照组小鼠全部存活。结论:γ射线照射可有效抑制NK-ustc细胞增殖,但保留该细胞对原代卵巢癌细胞的杀伤活性。 Objective: To explore the cytotoxic activity of IL-15 gene modified-NK cells (NK-ustc cells) against pri- mary ovarian cancer cells in vitro and in vivo. Methods: Primary ovarian cancer cells were isolated from ascites of patients. NK-uste cells were irradiated with different dosages of gamma ray (0, 1, 2, 4, 8, 16 Gy) , and the proliferation of irradiated NK-ustc cells were detected by 3 H-TdR incorporation assay. Cytotoxic activities of NK-ustc cells against K562 and primary ovarian cancer cells were measured by 51Cr release assay. The tumor-bearing mouse model was established using primary ovarian cancer cells and randomly divided into NK-ustc treatment group ( intraperitoneal injection of 8 Gy irradiated NK-ustc cells) and medium control group; moreover, blank control group (8 Gy irradiated NK-ustc cells were in- jected into nude mice) was also included in the present study. The body weight, abdomen circumference and survival time of nude mice were monitored. Results: After 1, 2, 4, 8 and 16 Gy irradiation, the proliferation rates of NK-ustc cells were (62. 1±9.8)% , (41.3 ±8.7)% , (14.6 ±4.1)%, (0.1±0.03)% and (0.2 ±0.04)% , respectively. The cytotoxic rates of 0 and 8 Gy irradiated-NK-ustc cells against K562 cells were (45.4 ± 8.9) % and (43.1 ±6.4) % when the effector to target ratio was 10: 1, and those against ovarian cancer cells were (54.6 ± 6.4)% and (48.3 ± 5.8 )%, respectively. Thus, irradiation had no influence on cytotoxicity of NK-uste cells (P 〉 0.05 ). The median survival time of irradiated-NK-ustc cells treated mice was 75 d, and that of control group was 39 d (P 〈 0.05 ). All the mice in the blank control group survived. Conclusion: Gamma ray irradiation can effectively inhibit proliferation of NK-ustc cells, but retain their cytotoxic activities against primary ovarian cancer cells.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2011年第4期409-413,共5页 Chinese Journal of Cancer Biotherapy
基金 安徽省科技攻关重大专项资助项目(No.08010302101)~~
关键词 自然杀伤细胞 IL-15基因 卵巢癌 免疫治疗 natural killer cell IL-15 gene ovarian carcinoma immunotherapy
  • 相关文献

参考文献23

  • 1Satthapong D, Tangjitgamol S, Manusirivithaya S, et al. Chemotherapy in patients with recurrent or refractory epithelial ovarian cancer [J]. J Med Assoc Thai, 2007, 90 (3) : 411-419.
  • 2Terme M, Ullrich E, Delahaye NF, et al. Natural killer cell-directed therapies: Moving from unexpected results to successful strategies [Jl. Nat Immunol, 2008, 9(5) : 486-494.
  • 3Malmberg K J, Bryceson YT, Carlsten M, et al. NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy [ J ]. Cancer Immunol Immunother, 2008, 57 (10) : 1541-1552.
  • 4Huntington ND, Legrand N, Alves NL, et al. IL-15 trans-presentation promotes human NK cell development and differentiation in vivo [J]. J Exp ned, 2009, 206(1): 25-34.
  • 5Jiang W, Zhang J, Tian Z. Functional characterization of interleukin-15 gene transduction into the human natural killer cell line NKL [J]. Cytotherapy, 2008, 10(3) : 265-274.
  • 6Zhang J, Sun R, Wei H, et al. Characterization of interleukin-15 gene-modified human natural killer ceils: Implications for adoptive cellular immunotherapy [ J ]. Haematologica, 2004, 89 (3): 338- 347.
  • 7Malmberg K J, Levitsky V, Norell H, et al. IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/ NKG2A-dependent mechanism [ J]. J Clin Invest, 2002, 110 (10) : 1515-1523.
  • 8Gong JH, Maki G, Klingemann HC. Characterization of a human cell line ( NK-92 ) with phenotypical and functional characteristics of activated natural killer cells [J]. Leukemia, 1994, 8 (4) : 652-658.
  • 9Friberg DD, Bryant JL, Whiteside TL. Measurements of natural killer (NK) activity and NK-cell quantification [ J ]. Methods, 1996, 9(2) : 316-326.
  • 10Hamilton TC, Young RC, Louie KG, et al. Characterization of a xenograft model of human ovarian carcinoma which produces ascites and intraabdominal carcinomatosis in mice [ J ]. Cancer Res, 1984, 44 ( 11 ) : 5286-5290.

二级参考文献25

共引文献41

同被引文献18

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部